Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Male-Specific cAMP Signaling in the Hippocampus Controls Spatial Memory Deficits in a Mouse Model of Autism and Intellectual Disability.

Zamarbide M, Mossa A, Muñoz-Llancao P, Wilkinson MK, Pond HL, Oaks AW, Manzini MC.

Biol Psychiatry. 2019 May 1;85(9):760-768. doi: 10.1016/j.biopsych.2018.12.013. Epub 2018 Dec 27.

PMID:
30732858
2.

Loss of the Intellectual Disability and Autism Gene Cc2d1a and Its Homolog Cc2d1b Differentially Affect Spatial Memory, Anxiety, and Hyperactivity.

Zamarbide M, Oaks AW, Pond HL, Adelman JS, Manzini MC.

Front Genet. 2018 Mar 2;9:65. doi: 10.3389/fgene.2018.00065. eCollection 2018.

3.

Cc2d1a Loss of Function Disrupts Functional and Morphological Development in Forebrain Neurons Leading to Cognitive and Social Deficits.

Oaks AW, Zamarbide M, Tambunan DE, Santini E, Di Costanzo S, Pond HL, Johnson MW, Lin J, Gonzalez DM, Boehler JF, Wu GK, Klann E, Walsh CA, Manzini MC.

Cereb Cortex. 2017 Feb 1;27(2):1670-1685. doi: 10.1093/cercor/bhw009.

4.

α-Synuclein-mediated inhibition of ATF6 processing into COPII vesicles disrupts UPR signaling in Parkinson's disease.

Credle JJ, Forcelli PA, Delannoy M, Oaks AW, Permaul E, Berry DL, Duka V, Wills J, Sidhu A.

Neurobiol Dis. 2015 Apr;76:112-125. doi: 10.1016/j.nbd.2015.02.005. Epub 2015 Feb 26.

PMID:
25725420
5.

Parallel mechanisms for direct and indirect membrane protein trafficking by synucleins.

Oaks AW, Sidhu A.

Commun Integr Biol. 2013 Nov 1;6(6):e26794. doi: 10.4161/cib.26794. Epub 2013 Nov 13. Review.

6.

Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking.

Oaks AW, Marsh-Armstrong N, Jones JM, Credle JJ, Sidhu A.

PLoS One. 2013 Aug 13;8(8):e70872. doi: 10.1371/journal.pone.0070872. eCollection 2013.

7.

Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.

Oaks AW, Frankfurt M, Finkelstein DI, Sidhu A.

PLoS One. 2013;8(4):e60378. doi: 10.1371/journal.pone.0060378. Epub 2013 Apr 1.

8.

Paraquat, but not maneb, induces synucleinopathy and tauopathy in striata of mice through inhibition of proteasomal and autophagic pathways.

Wills J, Credle J, Oaks AW, Duka V, Lee JH, Jones J, Sidhu A.

PLoS One. 2012;7(1):e30745. doi: 10.1371/journal.pone.0030745. Epub 2012 Jan 23.

9.

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease.

Kaul T, Credle J, Haggerty T, Oaks AW, Masliah E, Sidhu A.

BMC Neurosci. 2011 Aug 3;12:79. doi: 10.1186/1471-2202-12-79.

10.

Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson's disease.

Haggerty T, Credle J, Rodriguez O, Wills J, Oaks AW, Masliah E, Sidhu A.

Eur J Neurosci. 2011 May;33(9):1598-610. doi: 10.1111/j.1460-9568.2011.07660.x. Epub 2011 Apr 1.

11.

Tauopathic changes in the striatum of A53T α-synuclein mutant mouse model of Parkinson's disease.

Wills J, Credle J, Haggerty T, Lee JH, Oaks AW, Sidhu A.

PLoS One. 2011 Mar 21;6(3):e17953. doi: 10.1371/journal.pone.0017953.

12.

Synuclein modulation of monoamine transporters.

Oaks AW, Sidhu A.

FEBS Lett. 2011 Apr 6;585(7):1001-6. doi: 10.1016/j.febslet.2011.03.009. Epub 2011 Mar 23. Review.

Supplemental Content

Support Center